Compare DTE & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DTE | ALC |
|---|---|---|
| Founded | 1903 | 1945 |
| Country | United States | Switzerland |
| Employees | 9650 | N/A |
| Industry | Electric Utilities: Central | Ophthalmic Goods |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4B | 35.9B |
| IPO Year | N/A | 2002 |
| Metric | DTE | ALC |
|---|---|---|
| Price | $140.93 | $62.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $153.31 | $89.38 |
| AVG Volume (30 Days) | 1.3M | ★ 1.8M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.17% | 0.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.99 |
| Revenue Next Year | $3.36 | $6.38 |
| P/E Ratio | ★ $20.29 | $38.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $126.23 | $63.84 |
| 52 Week High | $154.63 | $92.55 |
| Indicator | DTE | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 37.66 | 22.83 |
| Support Level | $132.91 | N/A |
| Resistance Level | $142.76 | $81.92 |
| Average True Range (ATR) | 2.97 | 1.68 |
| MACD | -0.78 | -1.45 |
| Stochastic Oscillator | 4.19 | 2.18 |
DTE Energy owns two regulated utilities in Michigan that contribute 90% of earnings. DTE Electric serves approximately 2.3 million customers in southeastern Michigan, including Detroit. DTE Gas serves 1.3 million customers throughout the state. In addition, DTE has nonutility businesses and investments including energy marketing and trading, renewable natural gas facilities, and on-site industrial energy projects.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.